|Dr. Avtar S. Dhillon||Exec. Chairman||N/A||N/A||1961|
|Mr. Christopher W. Wagner||Consultant||N/A||N/A||1969|
|Mr. Riaz Bandali||CEO & Pres||N/A||N/A||1970|
|Ms. Jenn Hepburn||CFO & Company Sec.||N/A||N/A||N/A|
|Mr. Michael Bierman||VP of Operations||N/A||N/A||N/A|
Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis in Canada. It is also involved in developing natural health products. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.
Emerald Health Therapeutics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.